logo
ScreenersREIT EarningsREIT SectorsIndustriesMarketplace
Logo

Champions Oncology, Inc.

CSBR

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care basā€¦ read more

Healthcare

Biotechnology

18 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$6.74

Price

-2.04%

-$0.14

$6.88

Previous Close

$6.75

Open

Premium

52w Discount
Market Cap

$92.911m

Small

Price/Earnings

32.1x

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$42.883m

-24.7%

1y CAGR

-6.0%

3y CAGR

-2.1%

5y CAGR
Earnings

$2.923m

-37.8%

1y CAGR

+30.1%

3y CAGR

-245.8%

5y CAGR
EPS

$0.20

-39.4%

1y CAGR

+27.8%

3y CAGR

-247.9%

5y CAGR
Book Value

$3.538m

$30.546m

Assets

$27.008m

Liabilities

$5.750m

Debt
Debt to Assets

18.8%

1.6x

Debt to EBITDA
Free Cash Flow

$7.240m

+3.5%

1y CAGR

-180.0%

3y CAGR

-153.4%

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
ā†‘ TopSummaryPriceFinancialsPress Releases
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.